Global Bariatric Surgery Devices Market: Snapshot
Bariatric surgery is mainly used to refer to the number of weight-loss procedures. Bariatric surgical procedures are carried out for the treatment of comorbid condition which are associated with morbid obesity, which require bariatric surgery devices. Bariatric surgery involves modification in the gastrointestinal tract by which either the amount of food that the stomach can intake is restricted or the nutrients that are absorbed in the intestinal tract are restricted.
Bariatric surgery is proven to be effective over alternate treatment options for obesity associated comorbid conditions and is also viable in terms of cost and faster recovery. Moreover, increasing number of facilities that offer bariatric surgical procedures and favorable government policies for bariatric procedures to be covered by insurance are favoring the bariatric surgery devices market.
The global bariatric surgery devices market was valued at US$798.3 mn in 2016 and is expected to reach US$1,744.1 mn by 2025 rising at a CAGR of 9.3% between 2017 and 2025.
This 141 page report gives readers a comprehensive overview of the bariatric surgery devices market. Browse through 19 data tables and 63 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/bariatric-surgical-devices.html
Closure Devices Segment to Register Leading CAGR due to Popularity of Minimally Invasive Surgeries
By devices type, assisting devices and implantable devices are the segments of the market. Assisting devices are further sub-segmented into suturing devices, closure devices, stapling devices, trocars, and others. In 2016, the segment of suturing devices held the leading share of the market due to high endorsement of these devices by surgeons. On the other hand, the closure devices segment is expected to register the leading CAGR as they devices are widely used in minimally invasive surgeries that require immediate closure of very small incision done at the time of surgical procedure.
The sub-segments of implantable devices are gastric bands, electric stimulation devices, gastric balloons, and gastric emptying. Among these, gastric bands account for the leading share as they are approved by regulatory agencies and are familiar to physicians as well as patients. Nevertheless, the segment of gastric balloons is expected to register the leading CAGR due to recent approvals from FDA that have proven them to be more safe and effective over other implantable devices.
On the basis of end-user, the bariatric surgery devices market is segmented into bariatric surgery clinics, hospital pharmacies, surgical centers, and others. Among these, in 2016, bariatric surgery clinics led the market due to the increasing popularity of minimally invasive surgeries that can be performed in bariatric surgery clinics. Bariatric surgery clinics are expected to expand at the leading CAGR during the forecast period as these facilities specialize in care needed for patients before and after the procedure. Also, bariatric surgery clinics are preferred by both patients and physicians as they are well-equipped for handling adverse situations.
Request a sample of this report to know what opportunities will emerge in the rapidly evolving bariatric surgery devices market during 2017 – 2025: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1369
Asia Pacific to Exhibit Robust Growth Rate
North America is the leading regional market for bariatric surgery devices on account of increasing incidence of obesity and associated comorbidities such as diabetes, sleep apnea predominantly in the U.S. In this region, sedentary lifestyle and increasing consumption of junk food has been the major causes of growing obesity. To address this, increasing number of individuals are undergoing bariatric surgery for weight loss to avoid further complications with the condition.
Europe is also a significant market for bariatric surgery devices due to a well-developed healthcare infrastructure and increasing spending on health and wellness.
However, Asia Pacific bariatric surgery devices market is expected to exhibit the leading growth in the forecast period. Rising economic prosperity in countries such as China and India has led to increased spending on convenience foods, leading to lifestyle diseases such as obesity. This, in turn, has led to the demand for bariatric surgical procedures.
The key players in the bariatric surgery devices market include Apollo Endosurgery Inc., Ethicon Inc., TransEnterix Inc., Agency for Medical Innovations, Cousin Biotech, EnteroMedics Inc., Medtronics Plc., Intutive Surgical Inc., Aspire Bariatrics Inc., and Mediflex Surgical Products.
Global Companion Diagnostic Tests in Oncology Market: Snapshot
The global companion diagnostic tests in oncology market is expected to register phenomenal pace owing to increasing adoption of new tests, and rising shift from blockbuster drugs to personalized medicines, and targeted therapies. Increasing incidence of cancer, rising cost burden of cancer treatment, and increasing mortalities due to cancer, are some of the major reasons for increasing demand for new and technologically advanced treatment options, therapies, and drugs for the treatment of cancer. Increasing focus on research and development by various pharmaceutical and biotechnology companies, along with medical device companies, and increasing funding and grants for cancer research by various government agencies have led to high adoption of companion diagnostic tests in oncology. According to the research report, the global companion diagnostic tests in oncology market is expected to be worth US$13.6 bn by the end of 2025 from US$3.5 bn in 2016. During the forecast period of 2017 and 2025, the global market is projected to rise at a CAGR of 16.8%.
This 232 page report gives readers a comprehensive overview of the companion diagnostic tests in oncology market. Browse through 42 data tables and 89 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/companion-diagnostic-tests-market.html
EGFR Biomarker to Remain Popular Amongst Pharmaceutical Companies
Among the biomarker segment, the EGFR biomarker segment accounted for the largest share of the global companion diagnostic tests in oncology market in 2016. It is expected to register highest CAGR during the forecast period of 2017-2025, owing to major factors such as increasing incidence of lung cancer, and rising R&D in biomarker segment. The HER2 and KRAS biomarkers are expected to register high CAGR during the forecast period, due to increasing incidence of cancer, and rising adoption of biomarker by pharmaceutical companies and research institutes. Analysts expect that the EGFR biomarker segment will register a CAGR of 18.4% over the forecast period.
Among the cancer types segment, the breast cancer segment accounted for the largest share of the global companion diagnostic tests in oncology market in 2016. However lung cancer segment is expected to register highest CAGR during the forecast period of 2017-2025, owing to increasing incidence of lung cancer in developing countries. This shift is attributable to the increased smoking and rising biomarker research for the lung cancer treatment. According to statistics from the World Health Organization (WHO), in 2013, an estimated 1.9 million new cases of lung cancer were diagnosed, and the stats reveled that less developed regions including the emerging countries such as China, India, and other countries, had the highest incidence of lung cancer, owing to rising smoking habits and poor air quality in these countries.
Request a sample of this report to know what opportunities will emerge in the rapidly evolving companion diagnostic tests in oncology market during 2017 – 2025: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4684
North America to Remain Dominant with Higher Acceptance of Technologies
Geographically, the global companion diagnostic tests in oncology market is segmented into North America, the Middle East and Africa, Asia Pacific, Europe, and Latin America. Analysts expect that North America will continue to dominate the global market due to the higher acceptance of technology in the region. Furthermore, better rate of diagnoses in the region is also likely to favor the regional market’s growth. By the end of 2025, the regional market is projected to account for a share of 37.5% in the global market. On the other hand, Asia Pacific is also expected to offer lucrative opportunities due to high rate of unmet medical needs in the emerging economies of the region.
Major players having presence in the global companion diagnostic tests in oncology market include F. Hoffman LA Roche Ltd., QIAGEN, Illumina, Inc., Abbott, Agilent Technologies, Inc., Genomic Health, Inc., bioMerieux SA, BioGenex, AGENDIA NV, Siemens Healthcare GmBH, and Thermo Fisher Scientific, Inc., among others.
Global Cancer Biomarkers Market: Snapshot
Cancer is a complex and potentially fatal disease that is primarily caused through environmental factors resulting in gene mutations affecting critical cell-regulatory proteins. These factors may act together or in a sequence to trigger tumor formation. Rising incidences of cancer and increasing healthcare expenditure are expected to aid the global cancer biomarkers market. The global market for cancer biomarkers is expected to grow at an exponential rate benefiting from the recent advances in technology, favorable government initiatives and funding.
Moreover, the development in companion diagnostics and recent breakthrough in detection techniques such as proteomics, metabolomics, genomics and transcriptomics are further expected to boost the demand for cancer biomarkers. Cancer biomarker is critical in improving early detection and treatment of any cancer type. Awareness and screening for cancer have increased over the last couple of decades resulting in early diagnosis of cancer and subsequent reduction of mortality. However, the ultimate goal of reducing mortality in late-stage cancer has not been satisfactorily achieved.
This 157 page report gives readers a comprehensive overview of the cancer biomarkers market. Browse through 18 data tables and 64 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/cancer-biomarkers-market.html
Besides this, the cancer biomarkers market is expected to gain from the rising geriatric population, increasing incidences of cancer, and increasing prevalence of tumor. Technological advancements in the field of biomarkers resulting in new and innovative products have increased the safety, improved efficacy and reduced the side effects. Spurred by these factors, the global cancer biomarkers market is forecast to exhibit a CAGR of 11.8% between 2017 and 2025. At this pace, the market is expected to reach US$27.63 bn by the end of 2025 from US$10.25 bn in 2016.
Lung Cancer Emerges as Leading Segment Based on Disease Indication
The CTC tests segment by test type accounted the largest share of the global cancer biomarkers market in 2016, and is expected to dominate the market during the forecast period from 2017 to 2025. Factors such as increase in prevalence of the various types of tumor and increasing incidences of cancer related to the vital organs drives the CTC tests segment. Although associated with non-drivers of selection, such as quick and easy order processing and availability from a contracted manufacturer, the cancer biomarkers market presents immense competition for new market players.
The lung cancer segment in terms of disease indication has the largest market share of the global cancer biomarkers market in 2016, and is expected to grow during the forecast period due to increasing prevalence of lung cancer in developing countries, growing cigarette smoking among the population, rising geriatric population, and technological advancements with regard to lesser side effects associated with biomarkers test and early detection of the illness drive demand for lung cancer diagnosis globally.
Request a sample of this report to know what opportunities will emerge in the rapidly evolving cancer biomarkers market during 2017 – 2025: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=479
North America to Remain Dominant Regional Market through Forecast Period
North America dominated the global cancer biomarkers market in 2016 and is expected to remain dominant through the forecast period. This is due to high prevalence of cancer, increasing health care expenditure leading to increase in demand for better diagnostic tests and health care services, and number of technological advancements in the field of cancer biomarkers. However, the market in Asia Pacific is projected to register a significant growth rate by 2025 due to availability of large patient pool and increasing awareness about health. In addition, high percentage of geriatric population, and increasing disposable income are expected to propel the market.
Major players operating in the global cancer biomarkers market include Abbott Laboratories, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Illumina, Inc., Agilent Technologies, QIAGEN, Merck & Co., Inc., Hologic, Inc., Novartis AG, bioMérieux SA, Genomic Health, Inc., are among others.
Global Blood Pressure Monitoring Devices and Accessories Market: Snapshot
The global market for blood pressure monitoring devices and accessories has been registering a remarkable rise in its valuation, thanks to the increasing prevalence of hypertension, technological advancements in the design and utilities of diagnostic devices, and the rise in the funding by public and private players to create awareness about hypertension.
On the other hand, the inaccuracy in the readings, owing to obesity or any pre-existing CV disorder, and the declining prices of blood glucose monitors are likely to create restraints in the growth trajectory of this market in the near future. However, the increasing need for blood pressure kiosks at public places, such as gym, airports, and colleges, and the rise in the government funding are anticipated to boost the production volume of blood pressure monitors over the next few years.
The opportunity in the worldwide market for blood pressure monitoring devices and accessories is likely to expand at a CAGR of 7.60% between 2016 and 2024, rising significantly from a value of US$1.14 bn in 2015 to US$2.20 bn by the end of 2024.
Obtain Report Details: http://www.transparencymarketresearch.com/blood-pressure-monitoring-market.html
Hospitals to Surface as Leading End User of Blood Pressure Monitoring Devices and Accessories
Hospitals, ambulatory surgical centers, clinics, and homecare settings are the key end users of blood pressure monitoring devices and accessories across the world. The demand for these devices and accessories is greater in hospitals than other end users. Thanks to the presence of trained and qualified personnel as well as favorable reimbursement structure in various parts of the world, this scenario is anticipated to remain so over the next few years.
Homecare settings will also report a significant increase in the demand for blood pressure monitoring devices and accessories in the near future, owing to the miniaturization of the devices, and the rising demand for self-serving diagnostic equipment by consumers. In clinics, the demand for these devices will be driven by the rising base of the geriatric population and the advancements in the healthcare facilities in developing countries. Ambulatory surgical centers are expected to display a moderate demand for blood pressure monitoring devices and accessories in the years to come.
Europe to Continue Generating High Revenues
Geographically, the global blood pressure monitoring devices and accessories market is stretched across North America, Middle East and Africa, Europe, Asia Pacific, and Latin America. In terms of revenue, Europe led the overall market in 2015 with a share of more than 32%. Researchers expect this regional market to remain the leading revenue contributor to the global market over the next few years. North America, on the other hand, has been and will continue to be the key regional market for blood pressure monitoring devices and accessories in terms of volume in the near future, thanks to the rising incidence of hypertension and the increasing demand for digitally and technologically advanced diagnostic devices among consumers.
Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1630
Amongst others, Asia Pacific is likely to witness considerable growth in the near future, owing to the rise in the number of regional players, increasing construction of research and development facilities by established companies in the developing countries, such as Japan and China, and the shift of population towards preventive healthcare. Latin America, however, is anticipated to experience a moderate rise over the coming years. Brazil and Mexico are likely to surface as the main domestic market for blood pressure monitoring devices and accessories in this region.
Omron Healthcare Inc., Koninklijke Philips N.V., Schiller AG, American Diagnostic Corp., American Diagnostic Corp., SPENGLER, Spacelabs Healthcare, Bosch + Sohn GmbH u. Co. KG, Withings SA, Welch Allyn Inc., SunTech Medical. Inc., A&D Medical, GE Healthcare
North America Wheelchair Accessible Vehicle Converters Market: Trends, Business Strategies and Opportunities with Key Players Analysis 2024
North America Wheelchair Accessible Vehicle Converters Market: Snapshot
The North America wheelchair accessible vehicle converters market has been displaying significant growth rate over the last few years, thanks to the increasing number of patients with disability. In the years to come, the market is likely to gain substantially from the rising demand for user-friendly accessible vehicles and the surge in the launch of affordable mobility gadgets. Apart from this, the mounting number of trauma cases, leading to disability and the escalating geriatric population is also expected to provide lucrative growth opportunities for the wheelchair accessible vehicle manufacturers in the near future.
In 2015, the North America market for wheelchair accessible vehicle converters was worth US$1.74 bn. According to researchers, the market’s future looks bright, rising at a CAGR of 5.30% from 2016 to 2024 and reaching US$3.47 bn by the end of 2024.
This 186 page report gives readers a comprehensive overview of the wheelchair accessible vehicle converters market. Browse through 38 data tables and 78 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/north-america-wheelchair-accessible-vehicle-converters-market.html
Full Size Vehicles to Continue as Leading Contributor to North America Market
On the basis of the type of vehicle, the North America market for wheelchair accessible vehicle converters has been classified into three broad categories, i.e., full size vehicles, medium size vehicles, and small size vehicles. Full size vehicles have been leading this market in terms of revenue; however, the demand for medium size vehicle is higher in North America. In 2015, the full size vehicle segment accounted for more than 48% of the overall market. With the increasing uptake of wheelchair accessible vehicles as family cars among families with disabled people, the revenue generated from this segment is likely to augment in the near future, ensuring its lead.
Based on the entry modality, the market has been categorized into ramps and lifts. The demand for ramps, which are mainly used for the medium size and small size vehicles, has been higher than lifts, which mostly find utilization in the case of a full size vehicle. The relatively low installation and maintenance costs of ramps have kept them a step ahead of lifts. The ramps segment led the North America wheelchair accessible vehicle converters market in 2015 with a share of 48.1%. Thanks to the ease of usage, ramps are expected to remain high in demand in this region over the next few years.
Request a sample of this report to know what opportunities will emerge in the rapidly evolving wheelchair accessible vehicle converters market during 2016 – 2024: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=16094
Demand from U.S. to Remain High
In terms of geography, the market for wheelchair accessible vehicle converters in North America has been segmented into the U.S. and Canada. With a share of nearly 95%, the U.S. led the overall market in 2015. The scenario is expected to remain so over the next few years, thanks to the presence of a large base of disabled population. The rising adoption of wheelchair accessible vehicles, stimulated by the increasing number of awareness initiatives by the manufacturers of vehicle converters, increasing cases of trauma resulting in disability, and the surge in the government funding for wheelchair accessible vehicles are also projected to boost the U.S. market for wheelchair accessible vehicle converters in the years to come.
The North America market for wheelchair accessible vehicle converters is fragmented and highly competitive in nature. Mobility Ventures LLC, Vantage Mobility International, and BraunAbility are at the forefront of this market. Some of the other prominent vendors of wheelchair accessible vehicle convertibles in this region are Toyota Motor Corp., Rollx Vans, and Freedom Motors USA.